The Italian neuromodulation startup Newronika has secured a European approval for its closed-loop, adaptive implant for ...
Medical Device Network on MSN4d
Newronika’s DBS device gains CE Mark approval for Parkinson’s treatmentNewronika has secured CE Mark approval for its AlphaDBS device aimed at the treatment of Parkinson's disease (PD), in Europe. This closed-loop deep brain stimulation (DBS) device claims to adjust the ...
Newronika announced today that it received CE mark approval for its AlphaDBS device for treating Parkinson's disease.
Hosted on MSN1mon
Newronika secures FDA’s IDE to begin adaptive deep brain stimulation system trialNewronika has received an investigational device exemption (IDE) for its adaptive deep brain stimulation (DBS) system from the US Food and Drug Administration (FDA), allowing it to begin a pivotal ...
Newronika, a leader in neuromodulation and adaptive deep brain stimulation (DBS) technology, announced today that it has ...
MILAN, Feb. 13, 2025 /PRNewswire/ -- Newronika, a global leader in advanced deep brain stimulation, is pleased to announce the successful closing of its €13.6 million Series B funding round.
MILAN, March 24, 2025 /PRNewswire/ -- Newronika, a leader in neuromodulation and adaptive deep brain stimulation (DBS) technology, announced today that it has received CE Mark approval for its ...
Newronika has secured CE Mark approval for its AlphaDBS device aimed at the treatment of Parkinson's disease (PD), in Europe. This closed-loop deep brain stimulation (DBS) device claims to adjust ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback